Medicaid

Medicaid Work Requiremnts

Tracking Medicaid Work Requirements: Data and Policies

To implement Medicaid work requirements, states will need to make important policy and operational decisions, implement needed system upgrades or changes, develop new outreach and education strategies, and hire and train staff, all within a relatively short timeframe. KFF is tracking key data and policy information related to Medicaid work requirements and how states are approaching implementation.

new and noteworthy

understanding medicaid

Medicaid Financing

Medicaid represents $1 out of every $5 spent on health care in the U.S. and is the major source of financing for states to provide health coverage and long-term care. This brief examines key questions about Medicaid financing and how it works.

Medicaid Program Integrity

This brief explains what is known about improper payments and fraud and abuse in Medicaid and describes ongoing state and federal actions to address program integrity.

Medicaid and Provider Taxes

All states except Alaska cover some state Medicaid costs with taxes on health care providers. This brief uses data from KFF’s 2024-2025 survey of Medicaid directors to describe current practices and the federal rules governing them.

Medicaid and Hospitals

Absorbing reductions in Medicaid spending could be challenging for hospitals, particularly for those that are financially vulnerable. This brief provides data on the reach of Medicaid across hospitals, patients, and charity care.

Medicaid Home Care

This issue brief provides an overview of what Medicaid home care (also known as “home- and community-based services”) is, who is covered, and what services were available in 2025.

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here

Filter

2,201 - 2,210 of 2,703 Results

  • The Implications of the Medicare Prescription Drug Benefit for Dual Eligibles

    Other Post

    Three new reports focus on one of the biggest challenges in the implementation of the Medicare Modernization Act, the transitioning of drug coverage for individuals dually eligible for Medicaid and Medicare, who now get their drug coverage from Medicaid, to the new Medicare benefit. The New Medicare Prescription Drug Law: Issues for Enrolling Dual Eligibles into Drug Plans Medicare's New Prescription Drug Benefit: The Voices of People Dually Covered by Medicare and Medicaid Implications of…

  • Medicaid Section 1115 Waivers: Current Issues

    Fact Sheet

    This fact sheet provides a brief introduction to Section 1115 waivers in the Medicaid program and highlights policy issues related to recent waiver activity. Fact Sheet (.pdf)

  • Medicaid:  Issues In Restructuring Federal Financing

    Issue Brief

    Medicaid: Issues In Restructuring Federal Financing This brief analysis summarizes how the possible restructuring of Medicaid financing could impact states, providers, and beneficiaries. Issue Brief (.pdf)

  • The Impact of Medicaid Reductions in Oregon:  Focus Group Insights

    Report

    The Impact of Medicaid Reductions in Oregon: Focus Group Insights Oregon is one state that has significantly restructured its Medicaid program, known as the Oregon Health Plan (OHP), in response to budget pressures. As part of these changes, it has implemented significant benefit reductions and increased premiums and cost sharing in it’s program for poor parents and other adults. This report presents findings from five focus groups conducted of current and former enrollees in Oregon’s…

  • State Fiscal Conditions and Medicaid – UPDATE

    Fact Sheet

    State Fiscal Conditions and Medicaid This fact sheet updates the current fiscal situation facing states, the impact the recent downturn in the economy had on Medicaid growth, and the cost containment actions being taken by states to curb Medicaid spending. Fact Sheet (.pdf)

  • Survey of Georgia Residents on HIV/AIDS: Summary and Chartpack

    Report

    The public in Georgia, and particularly African Americans, are concerned about HIV/AIDS as a problem facing the nation. Most believe that the U.S. is losing ground when it comes to HIV/AIDS, and most would like to see the government increase spending to fight the disease in the U.S. This statewide representative survey examines Georgians views on the HIV/AIDS epidemic in their state and local communities, their knowledge and misconceptions about HIV/AIDS, Georgia's HIV testing rates,…

  • HIV/AIDS in Georgia

    Report

    Two reports - "Survey of Georgia Residents on HIV/AIDS" and "Georgia's Minority Health and Health Disparities Report - Facing a Crisis" - show the disproportionate impact HIV is having on minorities in Georgia, and important differences in how minorities view HIV/AIDS compared to whites. The reports were released at a November 30, 2004 briefing held by the National Center for Primary Care (NCPC) at the Morehouse School of Medicine in partnership with the Kaiser Family…

  • Prescription Drug Spending Under The MMA: Modeling The Impact On Out-of-Pocket Costs

    Event Date:
    Event

    This report projects the impact of the new Medicare drug benefit on out-of-pocket spending for people who enroll in 2006. The analysis is based on a model developed by the Actuarial Research Corporation for the Kaiser Family Foundation. The model generally conforms to the Congressional Budget Office’s assumptions and projections about Medicare drug benefit spending and participation rates for the new benefit and for the low-income subsidy. The report was released at a briefing in…

  • Estimates of Medicare Beneficiaries’ Out-of-Pocket Drug Spending in 2006

    Report

    This report projects the impact of the new Medicare drug benefit on out-of-pocket spending for people who enroll in 2006. This analysis from November 2004 estimates that 6.9 million beneficiaries are projected to be affected by the coverage gap (the so-called "doughnut hole") in the standard Part D drug benefit. This estimate is based on projected enrollment in Part D plans of 29 million (Congressional Budget Office, July 2004), prior to implementation of the drug…